1. |
Xu F, Zhu J, Sun N , et al. Development and validation of prediction models for hypertension risks in rural Chinese populations. J Glob Health 2019; 9(2):020601. doi: 10.7189/jogh.09.020601.
|
2. |
Guyenet PG . The sympathetic control of blood pressure. Nat Rev Neurosci 2006; 7(5):335-46. doi: 10.1038/nrn1902.
|
3. |
Lifton RP, Gharavi AG, Geller DS . Molecular mechanisms of human hypertension. Cell 2001; 104(4):545-56. doi: 10.1016/s0092-8674(01)00241-0.
|
4. |
Bruno RM, Di Pilla M, Ancona C , et al. Environmental factors and hypertension. Curr Pharm Des 2017; 23(22):3239-46. doi: 10.2174/1381612823666170321162233.
|
5. |
Oparil S, Schmieder RE . New approaches in the treatment of hypertension. Circ Res 2015; 116(6):1074-95. doi: 10.1161/CIRCRESAHA.116.303603.
|
6. |
Takimoto-Ohnishi E, Murakami K . Renin-angiotensin system research: from molecules to the whole body. J Physiol Sci 2019; 69(4):581-7. doi: 10.1007/s12576-019-00679-4.
|
7. |
Karnik SS, Unal H, Kemp JR , et al. International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin receptors: interpreters of pathophysiological angiotensinergic stimuli [corrected] [publicshed correction appears in Pharmacol Rev. 2015 Oct;67(4):820]. Pharmacol Rev 2015; 67(4):754-819. doi: 10.1124/pr.114.010454.
|
8. |
Forrester SJ, Booz GW, Sigmund CD , et al. Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology. Physiol Rev 2018; 98(3):1627-738. doi: 10.1152/physrev.00038.2017.
|
9. |
Sparks MA, Crowley SD, Gurley SB . Classical renin-angiotensin system in kidney physiology. Compr Physiol 2014; 4(3):1201-28. doi: 10.1002/cphy.c130040.
|
10. |
Carey RM, Siragy HM . Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation. Endocr Rev 2003; 24(3):261-71. doi: 10.1210/er.2003-0001.
|
11. |
de Gasparo M, Catt KJ, Inagami T . International Union of Pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000; 52(3):415-72.
|
12. |
Wang Z, Gerstein M, Snyder M , et al. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 2009; 10(1):57-63. doi: 10.1038/nrg2484.
|
13. |
Satoh K, Nigro P, Matoba T , et al. Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms. Nat Med 2009; 15(6):649-56. doi: 10.1038/nm.1958
|
14. |
Xu H, Qing T, Shen Y , et al. RNA-seq analyses the effect of high-salt diet in hypertension. Gene 2018; 677:245-50. doi: 10.1016/j.gene.2018.07.069.
|
15. |
Pan X, Shao Y, Wu F , et al. FGF21 prevents angiotensin II-induced hypertension and vascular dysfunction by activation of ACE2/angiotensin-(1-7) axis in mice. Cell Metab 2018; 27(6):1323-37.e5. doi: 10.1016/j.cmet.2018.04.002.
|
16. |
Tang X, Chen XF, Wang NY , et al. SIRT2 acts as a cardioprotective deacetylase in pathological cardiac hypertrophy. Circulation 2017; 136(21):2051-67. doi: 10.1161/CIRCULATIONAHA.117.028728.
|
17. |
Song Y, Milon B, Ott S , et al. A comparative analysis of library prep approaches for sequencing low input translatome samples. BMC Genomics 2018; 19(1):696. doi: 10.1186/s12864-018-5066-2.
|
18. |
Bolger AM, Lohse M, Usadel B . Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 2014; 30(15):2114-20. doi: 10.1093/bioinformatics/btu170.
|
19. |
Roberts A, Trapnell C, Donaghey J , et al. Improving RNA-Seq expression estimates by correcting for fragment bias. Genome Biol 2011; 12(3):R22. doi: 10.1186/gb-2011-12-3-r22.
|
20. |
Trapnell C, Williams BA, Pertea G , et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 2010; 28(5):511-5. doi: 10.1038/nbt.1621.
|
21. |
Anders S, Huber W . Differential expression of RNA-Seq data at the gene level-the DESeq package. Heidelberg, Germany: European Molecular Biology Laboratory (EMBL) 2012; 10 f1000research.
|
22. |
Kanehisa M, Araki M, Goto S , et al. KEGG for linking genomes to life and the environment. Nucleic Acids Res 2008; 36(Database issue):D480-D4. doi: 10.1093/nar/gkm882.
|
23. |
Mitteer DR, Greer BD, Fisher WW , et al. Teaching behavior technicians to create publication-quality, single-case design graphs in graphpad prism 7. J Appl Behav Anal 2018; 51(4):998-1010. doi: 10.1002/jaba.483.
|
24. |
Yan YF, Pei JF, Zhang Y , et al. The paraoxonase gene cluster protects against abdominal aortic aneurysm formation. Arterioscler Thromb Vasc Biol 2017; 37(2):291-300. doi: 10.1161/ATVBAHA.116.308684.
|
25. |
Lopez Gelston CA, Mitchell BM . Recent advances in immunity and hypertension. Am J Hypertens 2017; 30(7):643-52. doi: 10.1093/ajh/hpx011.
|
26. |
Thenappan T, Chan SY, Weir EK . Role of extracellular matrix in the pathogenesis of pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol 2018; 315(5):H1322-H31. doi: 10.1152/ajpheart.00136.2018.
|
27. |
Vélez EJ, Perelló M, Azizi S , et al. Recombinant bovine growth hormone (rBGH) enhances somatic growth by regulating the GH-IGF axis in fingerlings of gilthead sea bream (Sparus aurata). Gen Comp Endocrinol 2018; 257:192-202. doi: 10.1016/j.ygcen.2017.06.019.
|
28. |
Higashi Y, Sukhanov S, Shai SY , et al. Insulin-like growth factor-1 receptor deficiency in macrophages accelerates atherosclerosis and induces an unstable plaque phenotype in apolipoprotein E-deficient mice. Circulation 2016; 133(23):2263-78. doi: 10.1161/CIRCULATIONAHA.116.021805.
|
29. |
Li Y, Higashi Y, Itabe H , et al. Insulin-like growth factor-1 receptor activation inhibits oxidized LDL-induced cytochrome C release and apoptosis via the phosphatidylinositol 3 kinase/Akt signaling pathway. Arterioscler Thromb Vasc Biol 2003; 23(12):2178-84. doi: 10.1161/01.ATV.0000099788.31333.DB
|
30. |
Burgos JI, Yeves AM, Barrena JP , et al. Nitric oxide and CaMKII: critical steps in the cardiac contractile response to IGF-1 and swim training. J Mol Cell Cardiol 2017; 112:16-26. doi: 10.1016/j.yjmcc.2017.08.014.
|
31. |
Andronico G, Mangano MT, Nardi E , et al. Insulin-like growth factor 1 and sodium-lithium countertransport in essential hypertension and in hypertensive left ventricular hypertrophy. J Hypertens 1993; 11(10):1097-101. doi: 10.1097/00004872-199310000-00014.
|
32. |
Vinciguerra M, Santini MP, Claycomb WC , et al. Local IGF-1 isoform protects cardiomyocytes from hypertrophic and oxidative stresses via SirT1 activity. Aging (Albany NY) 2009; 2(1):43-62. doi: 10.18632/aging.100107.
|
33. |
Vinciguerra M, Santini MP, Martinez C , et al. mIGF-1/JNK1/SirT1 signaling confers protection against oxidative stress in the heart. Aging Cell 2012; 11(1):139-49. doi: 10.1111/j.1474-9726.2011.00766.x
|
34. |
Masternak MM, Al-Regaiey KA, Del Rosario Lim MM , et al. Caloric restriction and growth hormone receptor knockout: effects on expression of genes involved in insulin action in the heart. Exp Gerontol 2006; 41(4):417-29. doi: 10.1016/j.exger.2006.01.009.
|
35. |
Zhu W, Cheng KK, Vanhoutte PM , et al. Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention. Clin Sci (Lond) 2008; 114(5):361-74. doi: 10.1042/CS20070347.
|
36. |
Hotta K, Funahashi T, Arita Y , et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20(6):1595-9. doi: 10.1161/01.atv.20.6.1595.
|
37. |
Pischon T, Girman CJ, Hotamisligil GS , et al. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004; 291(14):1730-7. doi: 10.1001/jama.291.14.1730.
|
38. |
Iwashima Y, Katsuya T, Ishikawa K , et al. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 2004; 43(6):1318-23. doi: 10.1161/01.HYP.0000129281.03801.4b.
|
39. |
Wang ZV, Scherer PE . Adiponectin, the past two decades. J Mol Cell Biol 2016; 8(2):93-100. doi: 10.1093/jmcb/mjw011.
|
40. |
Lakatta EG . Central arterial aging and the epidemic of systolic hypertension and atherosclerosis. J Am Soc Hypertens 2007; 1(5):302-40. doi: 10.1016/j.jash.2007.05.001.
|
41. |
Cunha PG, Boutouyrie P, Nilsson PM , et al. Early vascular ageing (EVA): definitions and clinical applicability. Curr Hypertens Rev 2017; 13(1):8-15. doi: 10.2174/1573402113666170413094319.
|
42. |
Nilsson PM, Lurbe E, Laurent S . The early life origins of vascular ageing and cardiovascular risk: the EVA syndrome. J Hypertens 2008; 26(6):1049-57. doi: 10.1097/HJH.0b013e3282f82c3e.
|
43. |
Nilsson PM, Boutouyrie P, Laurent S . Vascular aging: a tale of EVA and ADAM in cardiovascular risk assessment and prevention. Hypertension 2009; 54(1):3-10. doi: 10.1161/HYPERTENSIONAHA.109.129114.
|
44. |
Guzik TJ, Skiba DS, Touyz RM , et al. The role of infiltrating immune cells in dysfunctional adipose tissue. Cardiovasc Res 2017; 113(9):1009-23. doi: 10.1093/cvr/cvx108.
|
45. |
Ungvari Z, Tarantini S, Donato AJ , et al. Mechanisms of vascular aging. Circ Res 2018; 123(7):849-67. doi: 10.1161/CIRCRESAHA.118.311378.
|
46. |
Jin J, Liu Y, Huang L , et al. Advances in epigenetic regulation of vascular aging. Rev Cardiovasc Med 2019; 20(1):19-25. doi: 10.31083/j.rcm.2019.01.3189.
|